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Type 1 diabetes (T1D) is an auto-immune disease characterized by the selective
destruction of the insulin secreting beta cells in the pancreas during an inflammatory
phase known as insulitis. Patients with T1D are typically dependent on the administration
of externally provided insulin in order to manage blood glucose levels. Whilst
technological developments have significantly improved both the life expectancy and
quality of life of these patients, an understanding of the mechanisms of the disease
remains elusive. Animal models, such as the NOD mouse model, have been widely used
to probe the process of insulitis, but there exist very few data from humans studied at
disease onset. In this manuscript, we employ data from human pancreases collected
close to the onset of T1D and propose a spatio-temporal computational model for the
progression of insulitis in human T1D, with particular focus on themechanisms underlying
the development of insulitis in pancreatic islets. This framework allows us to investigate
how the time-course of insulitis progression is affected by altering key parameters, such
as the number of the CD20+ B cells present in the inflammatory infiltrate, which has
recently been proposed to influence the aggressiveness of the disease. Through the
analysis of repeated simulations of our stochastic model, which track the number of beta
cells within an islet, we find that increased numbers of B cells in the peri-islet space lead to
faster destruction of the beta cells. We also find that the balance between the degradation
and repair of the basement membrane surrounding the islet is a critical component in
governing the overall destruction rate of the beta cells and their remaining number. Our
model provides a framework for continued and improved spatio-temporal modeling of
human T1D.
Keywords: type 1 diabetes, insulitis, agent-based modeling, spatio-temporal dynamics, peri-islet basement
membrane
1. INTRODUCTION
Type 1 diabetes (T1D) is an auto-immune disease characterized by the selective destruction of
pancreatic beta cells in the islets of Langerhans by the immune system (Eisenbarth, 1986; Atkinson,
2012; Boitard, 2012; La Torre and Lernmark, 2012; Pugliese, 2014; Richardson et al., 2014; Roep
and Tree, 2014). This destruction takes place during an inflammatory phase, known as insulitis, in
which various immune cells infiltrate the islets (Lecompte, 1958; Gepts, 1965; Willcox et al., 2009;
Morgan et al., 2014). As the beta cell mass decreases over the course of the disease, the ability of
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the islets to secrete sufficient quantities of insulin to properly
regulate blood glucose levels becomes compromised. As a result,
patients with type 1 diabetes ultimately become reliant on the
lifelong administration of external insulin.
Well-defined genetic components have been identified which
predispose individuals to T1D; in particular the HLA-genotype
(Itoh et al., 1993; Somoza et al., 1994). However, this alone is not
sufficient to predict which individuals will develop the disease
with precision. Since monozygotic twin studies have shown
limited pairwise concordance for T1D (Barnett et al., 1981; Lo
et al., 1991; Redondo et al., 2001), it is clear that environmental
factors, such as viral infection, vitamin D status and childhood
nutrition may also contribute significantly to the development of
T1D (Knip et al., 2005).
Among the different subtypes of immune cells which infiltrate
islets, CD8+ T cells are considered as the likely mediators of
beta cell destruction (Bottazzo et al., 1985; Itoh et al., 1993;
Somoza et al., 1994). It is widely believed that these promote beta
cell apoptosis by both direct and indirect mechanisms and that
macrophages then clear dying and dead beta cells very quickly.
Other T lymphocytes, such as those expressing CD4, are also
thought to play a role, though their precise functions are less clear
(Willcox et al., 2009; Richardson et al., 2011). In addition to the
T cells, B lymphocytes (CD20+) are also present in significant
numbers during certain stages of insulitis in some patients.
Indeed, recent evidence has suggested that the number of B cells
and/or the ratio of B-cells to CD4+ cells present in the infiltrate
can be used to classify the disease into two distinct phenotypes.
These have been defined as “hyper-immune,” characterized by
elevated numbers of CD20+ cells and a rapid loss of beta cell
mass whereas, by contrast, the “pauci-immune” phenotype, is
associated with a lower proportion of B cells and a much slower
destruction of beta cells (Morgan et al., 2014; Leete et al., 2016).
The mechanisms by which the B cells affect the rate of disease
progression are unknown, but it is possible that they collaborate
with CD8+T cells to drive beta cell loss (Huppa andDavis, 2003).
Progress in understanding the cellular and molecular
mechanisms underlying insulitis in humans has been hindered
by the paucity of available samples from patients who died at, or
close to, disease onset. Fewer than 200 such samples are available
worldwide (Gepts, 1965; Foulis and Stewart, 1984; Klöppel et al.,
1985; Dotta et al., 2007; Walker et al., 2011; Campbell-Thompson
et al., 2012; Pugliese, 2014), and inferring the time course of
a disease process from histological samples is fraught with
difficulty since a range of assumptions and extrapolations about
the likely progression are inevitably required to achieve this.
To offset this problem, much work has been performed using
animal models such as the non-obese diabetic (NOD) mouse
as a proxy for the human condition (Kachapati et al., 2012).
The advantages of this are clear—experiments can be performed
over relatively short periods of time and analysis of circulating
and pancreatic lymphyocyte populations is achievedmore readily
during the course of disease. Such studies have, therefore, been
extremely informative as a means to identify important cellular
and molecular factors involved (Lally and Bone, 2003), although
considerable effort needs to be made to verify that results are
translatable to humans. While a large number of potential
therapies have been identified in rodents, a means to prevent
the human disease remains elusive (Brehm et al., 2012; In’t Veld,
2014; Pugliese et al., 2014; Reed and Herold, 2015).
An alternative approach, which may shed light on human
insulitis is offered by mathematical modeling. By constructing
environments that mimic the pancreas and immune system,
experiments can be performed in silico, and the results compared
to empirical data arising from studies of relevant human
tissue. Through model construction and analysis, candidate
mechanisms giving rise to T1D can be interrogated in a
systematic way. To this end, a number of authors have developed
models describing: beta cell function (Bertram and Sherman,
2004), defective macrophage clearing (Marée et al., 2006),
immune cell populations (Mahaffy and Edelstein-Keshet, 2007),
multi-clonal populations of immune cells (Khadra et al., 2009,
2011; Jaberi-Douraki et al., 2015), immune cell cycles (Jaberi-
Douraki et al., 2014b), and apoptotic stress generated by the loss
of beta cell mass (Jaberi-Douraki et al., 2014c).
A common theme among the models outlined above is that
they can be regarded as “lumped models,” in that they deal
with averaged quantities taken over the whole body. For certain
applications, this seems appropriate, as it is commensurate
with current clinical practice. The biomarkers clinicians have
available are typically derived from blood samples, in particular,
measures of HbA1c and fasting glucose levels (American
Diabetes Association, 2006; Inzucchi, 2012). Other biomarkers,
such as measures of C-peptide (NIC, 2015) and islet cell and
anti-insulin antibodies (Taplin and Barker, 2008) can be used
to identify individuals who may be susceptible to diabetes
and, though it is not currently routine clinical practice, they
can also be used to aid classification of diabetes (Jones and
Hattersley, 2013). Biomarkers obtained from blood samples are,
by their nature, whole body measures. However, it is known from
histological samples that insulitis displays a pronounced spatial
dependence (Willcox et al., 2009; Morgan et al., 2014). This is due
in part to the distribution of the islets within the pancreas, but
is also a consequence of the presence of a basement membrane
around the islets (Korpos et al., 2013), establishing a barrier
to immune cell infiltration. Interactions and communication
between immune cells also play a role and are likely to contribute
to this spatial dependence.
Insulitis is a spatially heterogeneous process, both within an
individual islet and across the pancreas as a whole. Islets that
are heavily infiltrated can be located near to islets that are free
from inflammation. Moreover, within an infiltrated islet, the
destruction of beta cells appears not to follow a “wave-like”
profile, as might be expected, but seems more random (Willcox
et al., 2009; Morgan et al., 2014). These observations lend
credence to the notion that immune cell communication is a
critical component of insulitis.
To investigate insulitis and its relevance to the progression
of T1D, these spatial aspects must thus be taken into account.
Moreover, since the number of immune cells infiltrating any
given islet is low (Willcox et al., 2009;Morgan et al., 2014), density
based approaches, such as ordinary differential equation (ODE)
modeling, cannot be applied with precision and alternatives are
required.
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In this manuscript, we construct an agent-based model of
the insulitis process within a single islet. The model is posed
on a regular domain that represents the space surrounding
the islet. The principal agents in our model are the immune
cells and we describe how they locate and target beta cells and
how they interact with one another. By using an agent-based
approach, we avoid the problems associated with density-based
(averaged) descriptions of cell mass. We begin by introducing
the relevant biology for our problem. Following this, we describe
the development of, and results from, the agent-based model
simulations. Finally, we conclude with a discussion of the model
and its potential extensions.
2. RELEVANT BIOLOGY
In this section, we highlight the biology corresponding to the
components of our model.
2.1. Cell Types
Our model consists of three distinct cell types—two types of
lymphocyte and the beta cells. We consider in particular CD8+ T
lymphocytes and CD20+ B lymphocytes. Of the various immune
cells that have been shown to be involved in human insulitis,
these are the ones that are believed to be most relevant to the
questions under investigation in our study. The CD8+ cells are
implicated in the destruction of the beta cells, while the CD20+
cells are deduced to play an important role, since their absence
is associated with a weakly aggressive phenotype (Morgan et al.,
2014). In our model, the B cells will essentially act as antigen
presenting cells to the T cells (Rodríguez-Pinto, 2005). We
assume thatmacrophages efficiently clear apoptotic beta cells.We
do not account for mitosis in any of the cell types; whilst division
and selection of relevant lymphocytes has been demonstrated in
the lymphatic system, evidence for it in the peri-islet space is
minimal (Willcox et al., 2010). Immune cells are assumed to have
a finite lifespan and beta cells die following interactions with T
cells (Cnop et al., 2010). We do not consider other cell types,
such as α and δ cells, that are also found within the islets of
Langerhans (Kim et al., 2009).
2.2. Basement Membrane
Individual islets are contained within an encapsulating
membrane. This membrane is comprised of various laminins
and collagen (Korpos et al., 2013) and acts as barrier to invading
immune cells. In mice with T1D, these compounds are lost,
suggesting that the basement membrane has been degraded.
In our model, we assume that the T cells are responsible for
degrading the membrane, but in principle, other cells could be
also responsible for this. We also make the assumption that the
membrane can be repaired over time.
2.3. Cell Movement
We assume that beta cells have a fixed location, but that immune
cells are free to move around. The direction of this movement
is mediated by a chemokine gradient, which will be described
below (Stein and Nombela-Arrieta, 2005). In addition, immune
cells of different types are attracted to one another, instigated by
different chemical signaling pathways (Janeway et al., 1985). Cells
are not allowed to pass through the basement membrane, nor
through each other, but are allowed to remain in contact with
one another.
2.4. Chemokine
The beta cells are considered to secrete a chemokine signal that
attracts immune cells toward the islet (Christen andVonHerrath,
2004). In our study, we assume that the chemokine molecules are
bound to the membrane of the beta cells and may also be cleaved
off so that they diffuse freely.
2.5. Cell Interactions
In their role as antigen presenting cells, the B cells can
cause the T cells to enter an activated state, in which both
their sensitivity to the chemokine gradient and their killing
efficiency are enhanced (Friedl et al., 2005). We assume that
activated T cells have a shorter lifespan than their non-activated
counterparts (Green et al., 2003).
When a T cell encounters a beta cell, it triggers a pro-apoptotic
pathway within the beta cell, ultimately resulting in the death of
the beta cell (Cnop et al., 2005).
The behavior of the cells and membrane are summarized
below.
2.6. Summary of Basic Behavior
Below, we will summarize the behavior of each of the cells types
included in our modeling.
T cells
• Move up chemokine gradients
• Degrade basement membrane
• Kill beta cells
• Interact with B cells
When activated by B cells, T cells become more sensitive to the
chemokine gradient and become more effective at killing beta
cells.
B cells
• Move up chemokine gradients
• Form productive interactions with T cells
• Activate T cells
Beta cells
• Immobile
• Killed by T cells
We do not include in our model the possibility of beta cell
replication. Studies have suggested that beta cell proliferation is
increased, particularly in the early stages of insulitis (Willcox
et al., 2010). Here, we disregard this effect.
Basement membrane
• Degraded by T cells.
• Can self-repair.
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3. METHODS
3.1. Building a Cellular Automaton
ODE-based modeling approaches average the dynamics
associated with insulitis over space essentially representing the
entire pancreas. Such approaches have provided numerous
insights into the potential roles of T and B cell involvement in
T1D and we refer the reader to Jaberi-Douraki et al. (2014a) for
a recent and comprehensive review of this literature. However,
we know that insulitis is heterogeneous and that the number
of immune cells directly involved in the destruction of the beta
cells in humans is low - far lower than would be necessary for
a density approximation to be justified (Willcox et al., 2009;
Morgan et al., 2014). Instead, we employ a different, agent-based,
modeling approach (An et al., 2009; Holcombe et al., 2012). Our
agents, the immune and beta cells, occupy finite area within a
two dimensional space. In a real islet, cells are free to move in
three dimensional space, but for ease of modeling (as a starting
point of first approximation) and for a more direct comparison
with data, we shall here restrict ourselves to the planar case. The
agents are given specific rules to locomote, interact with one
another and with the basement membrane. Simulations will then
be performed to track emergent behavior arising from the basic
rules. In this way, the model will evolve over a spatially extended
domain in which cell-cell interactions can be explicitly defined.
Note that the rules that govern our agents’ dynamics are
not intended to be exhaustive lists for all potential behaviors
exhibited by the cells. Instead, they are intended to represent
a minimal set of interactions that can explain the observed
phenomena. Additionally, the model can be iteratively developed
to account for new interactions as required.
3.2. Cell Movement
In this modeling framework, the cells are treated as being discrete
circular particles (Levine et al., 2000; Palsson and Othmer, 2000;
Tijskens et al., 2003;Maini and Baker, 2011; Bruna andChapman,
2012; Plank and Simpson, 2012). Cell movement is simulated by
modeling the forces that act upon cells from different sources
and then by resolving these forces using Newton’s second law
of motion. In the absence of external forces, intrinsic forces
acting upon the immune cells cause them to diffuse randomly,
obeying a random walk. In the presence of a chemokine gradient,
these same cells will seek to move up the gradient. Cells may be
attracted to one another and may be in contact with one another
for extended periods of time, that is, we allow cells to overlap, but
they may not pass through each other.
3.3. Immune Cell Forces
Before discussing the governing equations, it is useful to define
indexing sets for each of the cell types. In the following, we define
the sets T , B, and β as sets containing the indices for T, B, and
beta cells respectively. From Newton’s second law of motion, we
have:
mi
d2xi
dt2
= −ηi
dxi
dt
+ Fi + σξi(t), i ∈ T ∪ B, (1)
for each cell where xi ∈ R2 is the cell’s location, mi ∈ R≥0 is the
mass of the cell, ηi ∈ R≥0 is the cell’s viscosity and Fi ∈ R2 is the
force acting on the cell. The final term in Equation (1) represents
a Gaussian white noise process: 〈ξ (t)〉 = 0, 〈ξ (t)ξ (t + s)〉 =
δ(t – s), with strength σ such that the immune cells perform
random walks in the absence of any other forces (Palsson and
Othmer, 2000; Middleton et al., 2014). In biological systems,
we assume that the cells have low Reynold’s numbers such that
inertial forces are small compared to viscous ones. Under this
approximation, we can replace (Equation 1) with:
dxi
dt
=
1
ηi
Fi + σξi(t), i ∈ T ∪ B
For simplicity, we set ηi = 1 for all cells. Note that, in a
general mathematical framework, specific values for ηi can be
absorbed into the definition of Fi. For our model definition, we
include heterogeneity between immune cells through variations
in their sensitivity to chemical gradients, as we shall discuss in
Section 3.11. We will also initially assume that the cells within
the subgroups are homogeneous with respect to their geometry,
that is, they share a common radius rimm.
The force F can be broken up into its constituent parts:
Fi = F
chemo
i + F
cell-cell
i + F
islet
i + F
β
i . (2)
In the above, Fchemoi represents chemotactic force, F
cell-cell
i
represents cell attraction and repulsion, whilst Fisleti represents
the interaction with the basement membrane and Fβi represents
interaction with the beta cells.
3.4. Chemokine Signaling
Since the chemokine is a chemical signal, we establish a gradient
using a reaction-diffusion equation:
∂C
∂t
= D∇2C + f (C). (3)
We assume that the chemokine evolves on a much faster
timescale compared to the movement of the cells, so we assume
the chemokine to be at steady state by setting the LHS of
Equation (3) to zero. The domain on which we simulate our
model represents only a small space around an individual islet.
We note that this region is small compared to the entire
pancreas, and further that the chemokine is free to diffuse out of
our prescribed region. Typically, when solving PDEs, boundary
conditions are applied at the edge of the domain over which
the equation is being solved. However, as we are treating our
region as only a small part of a much larger one, we feel it is
more appropriate to not apply boundary conditions, leaving them
open. The reaction term is given by local decay with point sources
given by the locations of the beta cells. The chemokine equation
now reads:
D∇2C = λC −
∑
j∈β
νj(t)δ(x− xj), (4)
where λ is the degradation rate of the chemokine and xj are the
centroids of the beta cells. To reflect the fact that dead beta cells
Frontiers in Physiology | www.frontiersin.org 4 December 2016 | Volume 7 | Article 633
Wedgwood et al. Insulitis Dynamics in Type-1 Diabetes
will not secrete chemokine, we assume that the production of
chemokine is dependent on the current viability of the cell νj(t).
For a viable beta cell, ν = 1, whilst dead beta cells have ν = 0.
This equation can itself be recast as:
QC =
∑
j∈β
νj(t)δ(x− xj), Q = (λ− D∇
2). (5)
The Green’s function for the operator Q at a given time is a
Gaussian function and so we lump parameters together and
choose a form for the chemokine signal given by:
C(x, t) =
∑
j∈β
ανj(t) exp
(
−(x− xj)
2/(2σ 2C)
)
, (6)
where α now represents the strength of the chemokine signal
and σC represents the range over which it decays. In order to
represent our assumption that the chemokine exists in forms in
which it is bound to the membrane and forms in which it freely
diffuses, we replace Equation (6) by:
C(x, t) =
2∑
k=1
∑
j∈β
ανj(t)C
k
0 exp
(
−(x− xj)
2/(2σ 2C,k)
)
, (7)
where σC,1 is small and reflects the membrane bound chemokine,
whilst Ck0, k = 1, 2 control the proportion of chemokine that is
membrane bound vs. that which is freely diffusing. The immune
cells respond to this gradient via:
Fchemoi = Si∇C,
where Si is the sensitivity of the i’th cell to the chemokine
gradient. We note that this represents the notion that immune
cells tend to move up a potential gradient in which the locations
of the beta cells are given by local peaks of this potential. The
use of such potentials to model forces is an integral part of this
modeling framework (Middleton et al., 2014).
3.5. Cell-Cell Interactions
We assume that T and B cells are attracted to one another.
For simplicity’s sake, we assume that this can be modeled via
another Gaussian function. It is worth noting that this could
represent attraction acting at a distance, or could represent a local
effect acting to keep cells in contact with one another (or some
combination of the two). We do not allow cells to pass through
one another. We can achieve both of these through the use of
another potential. Common choices for these potentials include
the Lennard–Jones potential and the Morse potential (Middleton
et al., 2014). We shall use the following potential:
Ucell-celli =
∑
j 6= i,j∈T ∪B
A
ij
a exp(−|xj − xi|
2/d2a)
− Ar(|xj − xi| − 2rimm)
6H(|xj − xi| − 2rimm).
(8)
The first of these terms is the attraction between immune cells of
different types—B cells seek out T cells to activate and T cells are
also attracted to B cells. This is achieved by setting:
A
ij
a =
{
A0a χi 6= χj
0 χi = χj
,
where χi is an indicator function taking value 1 if cell i is a T cell
and 0 if it is B cell. The spatial scale of this attraction is set by da.
The second term accounts for the fact that cells cannot pass
through one another. If the distance between cells is greater
than the sum of their radii, that being 2rimm, they exert no
repulsive force on one another, achieved through the inclusion
of a Heaviside function H. However, if this distance falls below
this sum, a large repulsive force is exerted. This is known as a
hard-core potential (Levine et al., 2000). Note that some authors
choose this potential to be infinite at the point of contact, so that
cells cannot occupy or share any part of physical space (Bruna
and Chapman, 2012). However, this necessitates choosing a
smaller time step and, since cells can remain in contact with one
another for significant periods of time, we will not make such
a choice. Note also that the parameter Ar is shared amongst all
immune cells. Once again, the forces acting on the i’th cell can
then be expressed as:
Fcell-celli = −∇U
cell-cell
i . (9)
Note that, since immune cells move around the domain, the
potential “landscape,” together with its peaks and troughs, is
constantly evolving.
3.6. Islet Interactions
For simplicity, and to remain consistent with our chosen
geometry of the cells, the basement membrane encapsulating the
islet is chosen to be a circle centred at the origin with radius R.
Cells cannot pass through the membrane, so when it is present,
immune cells remain on the inside or outside of the islet. This
can be reflected through the use of another hard-core potential.
Whilst we have not yet defined the dynamics for the membrane,
we shall assume that there is a integrity threshold, h, below which
the membrane does not prevent cells from passing through. Since
we do not expect the membrane to have the same integrity across
its whole length, we also need to account for the location at which
the cell interacts with the islet. The relevant hard-core potential
is then given by:
U isleti = AisletH(m(θ)− h)H(rimm − |di − R|)
(rimm − |di − R|)
6, (10)
di = |xi − xislet|,
where m(θ) ∈ [0, 1] is the membrane integrity at angle θ ∈ S1
around the membrane, xislet ∈ R2 is the location of the center
of the islet and Aislet is a constant indicating the strength of
repulsion. Once more, the force acting on the cells is then given
by:
Fisleti = −∇U
islet
i . (11)
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Finally, we must define the forces acting upon the immune cells
exerted by the beta cells. This is functionally the same as the
repulsive force between cells (Equation 8) and is given by:
U
β
i = Ar
∑
j∈β
νj(t)H(|xj − xi| − (rβ + rimm))
(|xj − xi| − (rβ + rimm))
6, (12)
where rβ is the radius of the beta cells. The time-dependence of νj
here reflects that the beta cells may die, after which we no longer
need to consider repulsive effects generated by them (assuming
the dead cell bodies are cleared by macrophages), and so νj is set
to 0 for that cell. The final force in Equation (2) is defined through
F
β
i = −∇U
β
i . (13)
3.7. Immune Cell Lifespan
The timescale over which insulitis takes place is long compared
to the average lifespan of an immune cell. Thus, we need to
incorporate immune cell death into our model. We assume that
T and B cells have a lifespan of LT, and LB respectively. Each cell
then has a counter χi, which is incremented by setting χi 7→
χi + 1 at each time step. Activated T cells are expected to have
shorter lifespans than unactivated T cells (Green et al., 2003), so
for those cells, we instead update the counter via χi 7→ χi +1χ
where1χ > 1.
When χi exceeds LT (or LB) for a given T (B) cell, it is
considered to be dead and is removed. We keep the number of T
and B cells constant throughout the simulation by assuming that
each dead cell is replaced by a newly arriving one.We assume that
the vasculature is sufficiently dense that immune cells can enter
at any point in the extra-islet space. As such, the location of the
new cell is drawn randomly from a uniform distribution over the
extra-islet space, achieved through the use of polar coordinates.
The cell’s counter is reset to 0 and, if the cell is a T cell, it is chosen
to be in the unactivated state.
3.8. Membrane Dynamics
In our simplified geometry, the encapsulating membrane is a
represented by a circle, which can be parameterized by a single
variable θ ∈ S1. The equation governing the evolution of the
membrane viability,m, is given by:
dm(θ)
dt
= αm(1−m(θ))
− λm
∑
i∈T
exp
(
−(|xi − xm(θ)| − rimm)/dm
)
, (14)
where αm and λm are respectively the repair and degradation
rates of the membrane and xm(θ) is the location in real space
of the membrane at position θ . The term in the sum represents
the fact that we expect T cells to break down the membrane and
this can only occur when T cells are close enough. The range over
which the T cells can degrade the membrane is set by dm.
We note that as beta cells are destroyed, the morphology of
the affected islets may change. In particular, some islets in T1D
present with small size and irregular outline (Gepts, 1965). The
membrane in our study, where it exists, simply follows a circle
with fixed radius, and thus does not account for these changes.
However, we note that not all degranulated islets have small size
and irregular outline (Gepts, 1965). Moreover, the morphology of
islets, irrespective of insulitis, is highly variable. It is thus difficult
to infer how themorphology of a given islet varies over the course
of the insulitic process. Nevertheless, it seems likely that changes
to islet morphology will occur, and we discuss approaches to
incorporate this into our model in Section 5.1.1.
3.9. Activation and Apoptosis
When T cells and B cells are in contact with one another, we
assume that B cells can activate non-activated T cells and that
this process has a characteristic time course. We thus describe
the activation level of the i’th T cell, ai, via:
dai
dt
=


∑
j∈B H(|xj − xi − 2rimm + 0.1|)
−λaai
ai < 1
0 ai ≥ 1,
, i ∈ T ,
(15)
where λa is the decay rate of the activation signal. The constant
0.1 is included inside the Heaviside function to account for
the fact that we are not explicitly modeling cell-cell contacts,
and the use of hard-core potentials tends to make cells move
apart quickly when they are close. Our specific choice for this
constant is selected such that cells are allowed to remain in
contact with one another. We note that if this value is selected
to be too large, cells can essentially occupy the same location,
whilst values that are too small will cause cells to “bounce” off
one another. We wish to avoid both of these behaviors, and over
a range of choices, we found that a value of 0.1 satisfied these
criteria. Once the activation signal reaches 1, the cell is activated
and remains so until that cell dies, (or until the end of the
simulation if that occurs first), reflected by setting the RHS to zero
upon the activation reaching 1. Activated cells have an increased
sensitivity to the chemokine signal and enhanced killing rate.
This is captured in the model by increasing the sensitivity and
killing parameters:
Si 7→ Si +1S, κi 7→ κi +1κ ,
where1S and1κ are positive constants.
The dynamics for the apoptosis of beta cells bi follows a similar
prescription:
dbi
dt
=


∑
j∈T κjH(|xj − xi − 2rimm + 0.1|)
−λbbi
bi < 1
0 bi ≥ 1,
, i ∈ β ,
where λb is the decay rate of the apoptotic signal, κj is the killing
rate of the j’th T cell, and we include the constant, 0.1, for the
same reasons as for (Equation 15). If bi exceeds 1 for a given cell
i, that cell is assumed to have been killed and is removed from the
simulation. This is achieved by setting its viability, νi, to be zero.
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3.10. Implementation
Since the system we are solving is a Langevin equation, we
must use an appropriate numerical method to deal with the
stochasticity. For computational efficiency, we shall use the
forward Euler–Maruyama scheme. This method only has strong
order dt1/2 but requires the fewest function evaluations of any
of the solvers for stochastic differential equations (SDEs). The
one exception to this is the equation governing the membrane
dynamics where the explicit Euler scheme is unstable and
causes solutions to blow up. For this equation, we use an
implicit, backward Euler scheme. This keeps the total order
accuracy of solutions consistent with the other equations, but
provides the required stability without incurring additional
computational cost.
Note that the membrane (Equation 14) treats distinct points
along the membrane as being distinct from one another. This
is the only system that is grid-based – all of the other equations
are grid-free. In order to solve this system, we first discretize the
membrane into Nθ points, θi = −π + 2π(i − 1)/Nθ , i = 1,N,
and subsequently solve (Equation 14) at each of these points. To
find the value of the m at a point not on the discrete grid, we
use band-limited interpolation for periodic signals as described
in Schanze (1995).
3.11. Initial Conditions and Parameters
The immune cells are initially located at random, non-
overlapping positions within annular domain with inner radius R
and outer radius 1mm. The islet is positioned at the center of the
domain, which for simplicity, we set as our origin. To distribute
the beta cells, Nβ cells are arranged in concentric circles within
the islet. Next, for T = 1000 timesteps, they are allowed to freely
evolve governed by:
dxi
dt
= Fisleti + F
β−β
i + σξi(t), i ∈ β , (16)
where xi is the center of the i’th beta cell, Fisleti is the same as
Equation (13) operating on the beta cells rather than the immune
cells with:
F
β−β
i = −∇U
β−β
i , (17)
where
U
β−β
i =
∑
j 6=i,j∈β
H(|xj − xi| − 2rβ )(|xj − xi| − 2rβ )
6, (18)
where xi ∈ R2 now represents the location of the beta cell. After
the n steps, the beta cells are fixed in location for the remainder
of the simulation. Note that during this process, the immune
cells are fixed in position. We distribute cells in this manner as
it (a) generates a more realistic islet geometry compared with
spacing them evenly within the islet and (b) it overcomes the
known computational problems with randomly distributing non-
overlapping disks in a confined region (Song et al., 2008). In
Figure 1, we show the initial and final configuration of the beta
cells following this approach. All simulations and analyses were
performed in Matlab.
FIGURE 1 | (A) Initial configuration of beta cells within an islet, distributed in
concentric circles. (B) Final configuration of the beta cells evolved for
T = 1000 timesteps, according to Equations (16–18).
Other initial conditions are given by m = 1 for all θ , ai = 0
for all i ∈ T , and bi = 0, νi = 1, ∀i ∈ β .
The sensitivities of the T and B cells to the chemokine gradient
are drawn from distinct Gaussian distribution with means ST and
SB and variances σT and σB respectively. Parameters governing
the geometry of our domain, such as immune cell and beta cell
sizes were chosen to be matched to available data. In particular,
beta cell diameters were taken from Saisho et al. (2013), immune
cell diameters were based on values found in Wang et al. (2012),
numbers of cells in each immune cell population were taken
from Willcox et al. (2009) and islet composition (in terms of
beta cells) were based on those found for humans in Kim
et al. (2009). Data regarding the in vivo lifespan of specific
effector lymphocytes in humans are rare and these may also
be heterogeneous even within the same population. However,
effector lymphocytes are unlikely to have lifespans ranging
beyond several weeks (Sprent, 1993). To address the uncertainty
in lifespans, we performed simulations across a range of values,
from 3 to 7 weeks and compared results.
Other parameters in our model were tuned to provide the
required behaviour, thoughwe comment thatmuch of the general
behavior observed in our simulations is robust to parameter
variations, suggesting that the model outcomes are robust. We
note that certain processes, such as the degradation and repair
of the peri-islet basement membrane, are phenomenological in
nature, and as such, it is difficult to ascribe to them meaningful
parameter values. Whilst the islet membrane is a physical
component of the real system, we represents its viability by
a scalar in the range 0–1, and so parameter values should be
interpreted with respect to this scaling. Similar comments hold
for the chemokine signal. Though a chemoattractant gradient
is thought to exist in the peri-islet space, it is not clear what
its composition, and subsequent properties, might be. As such,
we have chosen a prototypical form to represent our chemokine
signal, and investigated how changes to the strength of this signal
impacts upon the resulting dynamics. All parameter values are
summarized in Table 1 and referenced in text where they are
altered for specific numerical experiments.
4. RESULTS
In Figure 2, we show the initial state of a prototypical simulation,
and the state of the system at T = 4000 days. Here, we
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TABLE 1 | Table of parameter values and meanings for the agent-based
model.
NT Number of T cells 30 Ref: Willcox et al. (2009)
NB Number of B cells {5, 30} Ref: Willcox et al.
(2009); Leete et al. (2016)
Nβ Number of beta cells 166 Ref: Kim et al. (2009)
σ Strength of Wiener process 1.0 µm days−1
rimm Radius of immune cells 4.0 µm Ref: Wang et al. (2012)
rβ Radius of beta cells 6.4 µm Ref: Saisho et al.
(2013)
R Radius of islet 120.0 µm Ref: Kim et al.
(2009)
ST Mean sensitivity of T cells 600 N
−8 µm mM−1
SB Mean sensitivity of B cells 700 N
−8 µm mM−1
σT Variance of sensitivity of T cells 0.5 N
−8 µm mM−1
σB Variance of sensitivity of B cells 0.5 N
−8 µm mM−1
κ Killing rate 0.2 cell−1 day−1
αC,1 Chemokine strength 0.5 µM
σC,1 Range of chemokine signal 200.0 µm
αC,2 Chemokine strength 10.0 µM
σC,2 Range of chemokine signal 8.0 µm
A0a Attraction strength between T and
B cells
1.0 N−8 µm
da Attraction range between T and B
cells
4.0 µm
Ar Repulsion rate for hard-core
potential between cells
10.0 N−8 µm
Aislet Repulsion rate for hard-core
potential of islet
100.0 µm
αm Repair rate of membrane 0.01 day
−1
λm Degradation rate of membrane 0.1 cell
−1 day−1
dm Membrane degradation range 4.0 µm
λa Decay rate of activation signal 0.5 day
−1
λb Decay rate of apoptotic signal 0.5 day
−1
1S Activated sensitivity boost 400 N−8 µm mM−1
1κ Activated killing rate boost 0.9 cell−1 day−1
LT Lifespan of T cells {21, 28, 56} days Ref: Sprent
(1993)
LB Lifespan of B cells {21, 28, 56} days Ref: Sprent
(1993)
1κ Activated killing rate boost 0.9 cell−1 day−1
1χ Activated cell lifespan counter 2
dt Time-step for EM scheme 0.001 day−1
Where indicated, references show the studies upon which specific parameter values were
based. Parameters are altered as discussed in the text for specific numerical experiments.
can see that the islet exhibits significant beta cell loss. We
also see that immune cells congregate at the islet membrane
and that a small number infiltrate the islet itself. Across
all parameter sets used in our experiments, this behavior is
preserved. In the Supplementary Material, we provide videos
showing the full time-course of typical simulations with base
parameters as indicated in Table 1, lymphocyte lifespan of
21 days and other parameters selected to reflect a variety of
conditions, as discussed in the forthcoming sections. These
simulations may be compared with the averaged results shown in
Figures 3–7.
FIGURE 2 | (A) Initial state of system. (B) State of the system after T = 4000
days. A video of the full time-course of this simulation can be found in the
Supplementary Material. In both panels, the blue circles represent beta cells,
the red circles represent T cells, the green circles represent B cells, the black
circle represents the peri-islet basement membrane and the black gradient
represents a chemokine signal. Parameters are as in Table 1.
For all parameter sets, we simulate 100 realizations and
average at specific time points to develop a time-course. During
the simulations, we keep track of the number of immune cells
within the islet and the number of viable beta cells. We take the
total area encompassing the viable beta cells as being reflective of
the beta cell mass. We shall now report both the time-courses of
the remaining beta cell mass as a percentage of the initial mass
(calculated as the ratio of the total mass of viable beta cells at
time t and the initial mass of beta cells, averaged over the 100
realizations), and the number of immune cells in the islet for a
number of conditions, along with the standard error of the mean
(SEM) at each time point. In each case, we shall use the base set
of parameters as indicated in Table 1, changing specific values
where indicated. In all cases, to assess how the lifespan of the
immune cells affects the resulting dynamics, we vary this between
21, 28, and 56 days as indicated in the figures.
4.1. Varying Number of B Cells
Webegin by examining a key condition in this study, namely how
the number of B cells in the peri-islet space impacts the rate of
destruction of beta cells. To address this, we compare a condition
with few B cells, settingNB = 5, and one with a higher number of
B cells, with NB = 30. These results are summarized in Figure 3.
We observe that when the immune cell lifespan is short,
neither the low nor the high B cell condition exhibit significant
beta cell destruction. As the lifespan is increased, we observe a
pronounced increase in this rate. For an immune cell lifespan
of 56 days, we see that the high B cell condition reaches an
equilibrium value at around 3000 days. Note that the equilibrium
value is below the critical threshold of ∼20% of remaining beta
cell mass (Cnop et al., 2005) (however, it should be noted that
this threshold is a whole-body threshold and may not be valid for
an individual islet).
4.2. Varying Repair Rate of Membrane
We have assumed in our model that the peri-islet basement
membrane is capable of being repaired at a rate αm. If we decrease
αm, the rate of degradation of the membrane may be such that
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FIGURE 3 | Effect of variation of B cell number on beta cell mass loss in the agent-based model. Each graph shows the mean ± SEM for 100 simulations.
Across all immune cell lifespans, we find that increasing the number of B cells significantly increases the destruction rate of the beta cells. Parameters are as in
Table 1. Videos of typical simulations for the case with immune cell lifespans of 21 days may be found in Videos S1, S2.
holes caused by infiltrating T cells are not repaired (at least
over the timescale of our simulation). In the extreme case, the
membrane is incapable of repair, in which case we set αm = 0.
In Figure 4, we display the time-course of a simulation in such a
regime.
It is clear from these graphs that removing the repair
mechanism of the membrane dramatically increase the
susceptibility of the beta cells to cytotoxicity. In the most extreme
case, in the situation with few B cells and a short immune cell
lifespan, we now see a huge difference in both the rate of beta cell
destruction and the final cell mass at the end of our simulation.
In the case with no membrane repair, the final beta cell mass
of almost all simulations is below ∼20% of the initial mass.
These results highlight the importance of the peri-islet basement
membrane to the progression of insulitis, and also suggest
that ongoing repair of this membrane is critical to slowing the
infiltration of the immune cells.
We also observe, in contrast to the results in Figure 3, that
the immune cell lifespan now has a more muted affect on the
resulting dynamics. Whilst there is an increase in the rate of
beta cell destruction with increasing lifespan, themore significant
contribution appears to be to lower the equilibrium value of
remaining beta cell mass. This likely arises due to the fact that,
as the beta cell population decreases, so too does the chemokine
signal to which the immune cells respond. This means that the
cells (on average) move into the islet at a slower rate, since their
paths becomes more dominated by noise. If the cell lifespan
is too short, the immune cells may die before entering the
islet if there are insufficient beta cells generating a chemokine
gradient.
4.3. Increasing the Membrane Degradation
Rate
Instead of reducing the basement membrane repair rate, we
now increase the efficacy of the immune cells of degrading the
membrane, setting λm = 0.2 and display the results in Figure 5.
For comparison with the condition in which the encapsulating
membrane is not repaired, we additionally plot results from this
case in the same figure, as indicated.
As expected, increasing the rate of membrane degradation
increases the rate of beta cell destruction and subsequently
decreases the final remaining beta cell mass. Compared with the
condition with no membrane repair, we see that the initial rate of
beta cell destruction is greater in the case with high membrane
degradation. However, as the insulitis process continues, this
trend becomes reversed. Remarkably, across all cases varying
the number of B cell and the immune cell lifespan, the time
at which this occurs appears to be approximately the same.
We also see that the final beta cell mass is lower for the
condition with no repair than for that with high membrane
degradation.
At the beginning of simulations, the ability of the T cells to
degrade the basement membrane at a faster rate allows them
to infiltrate the islet and subsequently kill the beta cells more
quickly. Whilst the initial degradation of the membrane in
the no repair condition is slower, the fact that “holes” in the
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FIGURE 4 | Time-course of beta cell mass comparing conditions with and without peri-islet basement repair. Each graph shows the mean ± SEM for 100
simulations. Data for simulations with 5 B cells are displayed in the left column, whilst those for simulations with 30 B cells are depicted in the right column. In the case
without membrane repair, we observe both an increase in the rate of beta cell destruction and pronounced differences in the final beta cell mass across all immune cell
lifespans and B cell number. Parameters are as in Table 1 with αm = 0. Videos of typical simulations for the case with immune cell lifespans of 21 days may be found
in Videos S3, S4.
encapsulating membrane caused by T cells are not repaired
means that, at later times, immune cells can simply pass through
these holes.
When the membrane can be repaired, the rate of immune
cell infiltration is governed by the balance between how quickly
it can be degraded and how quickly it can be repaired. As the
chemokine signal across the peri-islet space becomes weaker
when beta cells die, the average rate that T cells reach the
basement membrane falls, since the strength of the signal is a
contributory factor in determinining the transit time for a T cell
toward the islet. As there are fewer T cells aggregrating at the islet
membrane at any given time, the degradation of the membrane
becomes slower, and hence the beta cells are destroyed at a slower
rate as time progresses. At later times the arrival rate of T cells
may be so slow that the membrane is repaired at the same rate as
it is degraded, on average, and so islet infiltration by the immune
cells will be halted.
These observations account for the slower rate of beta
cell destruction and higher remaining beta cell mass for
the high degradation condition compared to that with no
membrane repair. This further highlights the importance
of continual basement membrane repair to the slowing of
insulitis.
4.4. Increasing the Killing Efficiency of the
T Cells
We now increase the killing rate of the T cells. To reflect the fact
that we assume that activated T cells are responsible for most of
the beta cell destruction, we achieve this by doubling the killing
rate boost, setting 1κ = 1.8. The results for these experiments
are displayed in Figure 6.
We observe that increasing the killing rate of the immune cells
does not significantly affect the death rate of beta cells, either
quantitatively or qualitatively. In all cases, we observe an increase
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FIGURE 5 | Time-course of beta cell mass comparing with higher membrane degradation rates. Each graph shows the mean ± SEM for 100 simulations.
The left column shows results for simulations with 5 B cells whilst the right column shows those with 30 B cells. Data for the condition with the base value for
membrane degradation but with αm = 0, as reported in Figure 4 are also shown. An increase in the beta cell destruction rate, as well as lower final beta cell masses
are observed across all immune cell lifespans and number of B cells. Note, however, that whilst the initial rate of beta cell destruction for the condition with high
membrane degradation is higher than that for the case with no membrane repair, the final beta cell mass is higher for the former compared with the latter. We refer the
reader to the text in Section 4.3 for further interpretation of this observation. Parameters are as in Table 1 with λm = 0.2 for the high degradation condition and
αm = 0 for the no membrane repair condition. Videos of typical simulations for the case with immune cell lifespans of 21 days may be found in Videos S5, S6.
in the beta cell mass destruction rate, but this is fairly minimal.
The limited impact of increased killing rate can be understood
by noting that, whilst the killing rate is an important factor in
the overall insulitis process, this is dominated by transit time to
and within the islet, as well as activation by B cells. Once inside
the islet, T cells can interact with and kill beta cells but the total
number of beta cells an individual T cell can destroy will be
influenced more strongly by its remaining lifespan than on its
killing rate. This highlights the need to incorporate the spatial
aspects of the immune response and that high T cell killing rates
do not necessarily significantly affect the progression of insulitis.
We comment that these observations at first seem at
odds with previous results from the NOD mouse where
the avidity of a T cell population is well-correlated with
its pathogenic potential, and the progression of T1D occurs
through avidity maturation (Amrani et al., 2000). Theoretical
studies have supported the viewpoint that higher avidity
CD8+ T cell populations lead to increased rates of beta cell
destruction (Khadra et al., 2011) and that low avidity populations
may have a protective effect against T1D development (Khadra
et al., 2009). However, recent results in the NOD model
have suggested that the highest avidity CD8+ cells do not
escape thymocyte negative selection, and accordingly, the cells
responsible for beta cell destruction in the murine pancreas
may be regarded as those with “intermediate avidity” (Han
et al., 2016). Furthermore, the paucity of data on the specificity
of lymphocytes involved in human insulitis makes it difficult
to propose quantitative statements about the effective killing
potential of individual T cells. This is particularly difficult
since the majority of the results regarding the avidity of
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FIGURE 6 | Time-course of beta cell mass comparing with higher activated killing rates. Each graph shows the mean ± SEM for 100 simulations. The left
column shows results for simulations with 5 B cells whilst the right column shows those with 30 B cells. Although an increase in the rate of beta cell destruction is
observed, this is relatively small in all cases. Parameters are as in Table 1 with 1κ = 1.8.
human lymphocytes come from peripheral blood measurements
and are not necessarily indicative of avidities within the
pancreas (Reijonen et al., 2004; Standifer et al., 2009). Finally, the
lifespan of a T cell that has successfully infiltrated an islet should
still have a significant impact on the number of beta cells it can
destroy, assuming its avidity is sufficiently high.
4.5. Increasing the Rate of Chemokine
Production
To reflect increases in the rate of chemokine production, we
now double α1C and α
2
C simultaneously, setting α
1
C = 1.0 and
α2C = 20.0. Note that, since we are assuming a quasi-steady state
approximation for the chemokine, this simply adjusts the profile
of the chemokine signal across our domain. The results for these
simulations are depicted in Figure 7.
As for the situation with increased killing rates, we observe
similar qualitative behavior to the case with lower chemokine
production rates. However, in contrast to the former case, the
quantitative differences between the beta cell death rate and
final cell mass are much greater. This further highlights the
contribution of cell movement in the overall inflammatory
response.
4.6. Combining High Chemokine Signals
and Reduced Membrane Repair
In our final numerical experiment, whose results are shown
in Figure 8, we simultaneously increase the strength of the
chemokine signal, setting α1C = 1.0, α
2
C = 20.0, as in the
previous subsection, and remove the membrane repair, setting
αm = 0. As expected, with these combined alterations, we now
observe significantly high rates of beta cell destruction for all
cases considered. Moreover, the final beta cell mass at the end
of our simulations is below 20% of the original cell mass. For the
cases with the longest lived immune cells, those having a lifespan
of 56 days, we now see that essentially all of the beta cells have
been destroyed within 1000 days.
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FIGURE 7 | Time-course of beta cell mass comparing conditions with the base and increased strength of chemokine signal. Each graph shows the mean
± SEM for 100 simulations. The left column shows results for simulations with 5 B cells whilst the right column shows those with 30 B cells. In the high chemokine
signal parameter regime, we observe both an increase in the rate of beta cell destruction and pronounced differences in the final beta cell mass across all immune cell
lifespans and B cell number. These differences are greater than those displayed for higher T cell killing rates in this figure. Parameters are as in Table 1 with α1
C
= 1.0
and α2
C
= 20.0. Videos of typical simulations for the case with immune cell lifespans of 21 days may be found in Videos S7, S8.
4.7. Immune Cell Invasion Profiles
We now consider how the invasion of immune cells is dependent
on the remaining beta cell mass and report the dependence of the
number of immune cells within the islet (i.e., within the basement
membrane) on the remaining beta cell mass. These results are
shown in Figure 9 for the case with 5 B cells and in Figure 10
for the case with 30 B cells. The results for the case with high
chemokine signals with no basement membrane repair, and for
the case with increased membrane degradation are omitted, but
are qualitatively similar to the case with no repair alone. In both
figures, we only show results when the immune cell lifespan is
56 days.
For situations with 5 B cells, we observe two qualitative
behaviors amongst the range of cases considered. Using the
default parameters and those with high killing rates, we observe
no infiltration of the islet by the B cells. The immune cell
population undergoes an initial increase to a maximum value,
followed by an approximately linear decay with the remaining
beta cell mass. The behavior with high chemokine signals or no
membrane repair does show islet invasion by the B cells. In these
cases, the T cell population now both increases and decreases
more gradually as a function of the beta cell mass, and attains
a higher maximum value than in either of the two previous cases.
If we now increase the number of B cells to 30, we observe, in
all cases, invasion of the islets by B cells and a qualitatively similar
profile of T cell infiltration. With the default parameters, or those
with high killing rates, the maximum value of invading T cells
occurs when approximately 50% of the beta cell mass remains.
In contrast to the T cell population, the number of invading B
cells varies little with the beta cell mass. In the case with no
membrane repair, this is no longer true, and we now find that the
B cell profile follows the T cell profile and furthermore, that the
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FIGURE 8 | Time-course of beta cell mass with high chemokine signals without basement membrane repair. Each graph shows the mean ± SEM for 100
simulations. The left column shows results for simulations with 5 B cells whilst the right column shows those with 30 B cells. In all cases, the rate of beta cell loss is
high and the remaining cell mass at the end of the experiments is low. Parameters are as in Figure 7 with αm = 0.
maximum value of immune cell infiltration occurs at low values
of the remaining beta cell mass.
4.8. Trial-to-Trial Variability and the Role of
Space
For each of the scenarios listed, we report the standard error of
the mean for all recorded values at each time point. In general,
we observe that variability across our simulations for a given
scenario is low, suggesting that the model behavior is robust
and that noise does not significantly affect the intrinsic model
dynamics. In particular, scenarios with either very high rates or
very low rates of beta cell destruction exhibit very little variability.
Variation is highest in scenarios that lead to intermediate rates of
beta cell death, suggesting that the role of noise in such situations
is much more significant in these conditions.
The results reported in Figures 3–10 reflect spatial averages
that are taken over the peri-islet space. As such, they do not
reflect the spatial component of the dynamics produced by the
agent-based model. These effects are, in general, quite subtle.
In particular, since we assume that activation of CD8+ cells
by CD20+ cells requires them to be co-localized, the spatial
arrangement of the immune cells will play an important role
in determining the overall rate of beta cell destruction. The
geometry in this initial version of the model has been chosen
to be simplistic in nature. In future versions, the geometry will
be adjusted to better match that of real islets as discussed in
Section 5.1.1. One could imagine scenarios in which the routes
taken by immune cells when migrating toward the islet could
influence the average number of interactions with one another,
and further, that these paths would be influenced by prominent
vasculature near the islet.
The spatial configuration of the immune cells also plays
a significant role in determining how quickly the basement
membrane is degraded. Where many CD8+ cells accumulate at
specific points along the periphery of the islet, we would expect
high rates of membrane degradation. Conversely, if the cells
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FIGURE 9 | Profiles of immune cell invasion dependent on the remaining beta cell mass in cases with 5 B cells. Each graph shows the mean ± SEM for
100 simulations. We report the number of T and B cells within the islet in a number of conditions. The top-left panel shows results using the parameters in Table 1, the
bottom-left uses these values with 1κ = 1.8, in the top-right, we set α1
C
= 1.0 and α2
C
= 20.0, and the bottom-right has αm = 0.
FIGURE 10 | Profiles of immune cell invasion dependent on the remaining beta cell mass in cases with 30 cells. Each graph shows the mean ± SEM for
100 simulations. We report the number of T and B cells in the same conditions as displayed in Figure 9.
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FIGURE 11 | Data showing the immune cell population against the
percentage of the islet which is positive for insulin, as calculated via
morphometry. This percentage can be thought of as being representative of
the residual beta cell mass. Each point is the mean ± SEM for the number of
relevant immune cells detected in each islet section, averaged over 279 islets
across 29 patients with T1D. The number of islets analyzed in each
insulin-positive category is given in parenthesis. Permission to reprint this
figure from Willcox et al. (2009) was granted by John Wiley and Sons (Licence
number: 3971831129485; www.interscience.wiley.com).
are evenly distributed along the membrane, average degradation
rates are likely to be low. Our results suggest that the dynamical
processes governing the repair and destruction of the basement
membrane play a key role in determining the overall rate of beta
cell destruction and so it is clear that the spatial distribution of
immune cells along this membrane will also be critical.
These spatial considerations are the key determinant for the
degree of variability observed between trials, as reported in
each of the figures. In the Supplementary Material, we provide
animations of typical simulations in a subset of the scenarios
listed to demonstrate the subtle role that these effects have on the
insulitis process.
5. DISCUSSION
In this manuscript, we have constructed a spatial, agent-based
model of immune cell invasion of a prototypical islet of
Langerhans. The agents in the model are immune and beta cells,
and each obeys rules that broadly match the general behavior
of these cell types. The model attempts to mimic a real islet,
allowing for in silico experiments to be performed through
model simulation. The agent-based framework allows both the
spatial aspects of insulitis to be investigated, and avoids issues
of applying ODE-based approaches to a system that has low cell
numbers. It is intended that this will lay down the framework
for more extensive spatio-temporal modeling of insulitis, with an
ultimate aim to understand its core mechanisms and to devise
strategies to slow or halt its progress.
Overall, the observed phenomena in the model are well
matched to real data, which have been collected and analyzed
from human patient samples (Willcox et al., 2009; Morgan et al.,
2014), and are reported in Figure 11. We note that data for
the pauci-immune phenotype have recently appeared in Leete
et al. (2016), but since our model is primarily focussed on
the hyper-immune phenotype, we highlight these results here.
Results from the agent-based model have the same qualitative
behavior as displayed by these data. This in turn provides
evidence that the mechanisms included within our model
are sufficient to capture qualitatively the key features of the
inflammatory response. In particular, we note that the case with
no membrane repair appears to provide the best qualitative
match to the existing data, in which we see a rise in the number
of infiltrating immune cells during disease progression, with
a peak at around 10–20% of remaining beta cell mass. We
note that scenarios with low overall rates of beta cell death
are associated with low levels of B cell infiltration. This further
supports the viewpoint that the CD20+ cells play an important
role in determining the rate of beta cell destruction. By adding
and removing mechanisms in a systematic way, we can probe
what effect their inclusion or exclusion will have on the resulting
dynamics and subsequent prognosis. It is important to note that,
since we investigate the disease at the level of the islets, we can
make predictions about how modifying certain cell properties
will affect the inflammation of the islets, rather than considering
whole body responses.
Accordingly, in the present study, we have performed several
parameter studies to examine how the relative contributions of
core processes affects insulitis.We have demonstrated that, under
the assumptions used in constructing the model, an increased
number of B cells in the peri-islet space gives rise to a faster
destruction of the beta cells. This effect can be amplified by
factoring in manipulations of other processes, such as the killing
rate of the beta cells by T lymphocytes and the repair rate of
the islet’s basement membrane. Simply increasing the killing rate
of the T cells did not have a significant impact of the rate of
the beta cell destruction. However, increasing the strength of the
chemokine signal to which the immune cells respond did show
a pronounced increase in the death rate. These facts highlight
the importance of the chemotactic process by which the immune
cells enter the islet, find and kill the beta cells.
In scenarios in which the islet basement membrane is unable
to repair itself, or is degradedmore rapidly, we also see significant
increases in the beta cell destruction. Moreover, we also find
that the final beta cell mass at the end of our simulations is
substantially depleted. This highlights the importance of this
membrane as a barrier to the infiltrating immune cells. In
particular, when chemokine signals are sufficiently high, if the
membrane is incapable of being repaired, all of the beta cells
may ultimately be killed, whereas in other situations, we find
residual beta cells even after long simulation times (not shown).
The importance of the basement membrane during insulitis in
our model is in line with a recent study of this membrane in
samples from human patients with T1D (Bogdani, 2016).
Upon examining the dependence of the immune cell invasion
on the remaining beta cell mass, we find in most cases the profile
of B cell infiltration is relatively flat. In cases with low B cell
numbers, low chemokine signals and with a membrane that is
repaired, there is essentially no B cell invasion. In situations with
higher numbers of B cells, the beta cell mass at which the T cell
invasion is maximal is shifted to lower values. In the case with
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no membrane repair, this maximal point is shifted to very low
values of the remaining cell mass. Moreover, in this instance,
we also see that the B cell invasion profile follows that of the
T cells. This condition is most consistent with the human data
reported in Willcox et al. (2009), suggesting that, for our model,
lowmembrane repair rates are an important factor in the insulitis
process.
The rise and subsequent decrease in T cell populations
observed in our simulations is in accordance with experimental
results of T1D specific autoimmune responses in the NOD
model (Trudeau et al., 2003). These dynamics have been
described as “waves” and have been explained mathematically by
transitions throughHopf and homoclinic bifurcations inMahaffy
and Edelstein-Keshet (2007) and by transient bistability of the
autoimmune state in Jaberi-Douraki et al. (2014b). Interestingly,
in the latter of these two theoretical studies, inclusion of multiple
clones of T cells with different avidities can give rise to multiple
waves in the T cell dynamics, which can significantly impact
the rate of overall beta cell destruction. This highlights potential
avenues for intervention through the promotion of lower avidity
T cell populations.
It should be noted that data on the specificities of T cells within
human insulitic islets are rare, but that cells with varying antigen
specificities may be present (Coppieters et al., 2012; Babon et al.,
2016). Thus, a potential development of our model would be to
include multiple clonal populations to explore these dynamics in
the spatial context, particularly given the potential insights that
may be applicable from the theoretical results in Mahaffy and
Edelstein-Keshet (2007) and Jaberi-Douraki et al. (2014b).
Agent-based and lattice-based approaches are becoming
increasingly popular in biological modeling. ODE based
approaches, which have long been a linchpin of the mathematical
biology community become ill fit for purpose when wishing
to describe processes in which the number of agents is small.
Considering stochastic variants of ODEs and partial differential
equations (PDEs) models is one potential approach to account
for the variability that arises from low cell numbers, but this
too is only a good approximation when the number of cells is
sufficiently high. Moreover, these approaches do not typically
account for trial-to-trial variability that may be important for
describing individual results. Note that, at various levels of
description, systems of differential equations can still form part
of agent-based models.
One of the attractive properties of ODE and PDE
modeling when compared with agent-based simulations is
the computational cost associated with the latter, whereas density
(continuum) based methods typically are low dimensional
in nature. Indeed, a significant barrier to the widespread use
of agent- and lattice-based models in the past has been the
requirement of significant computational power. In recent years,
the technological advances in computing have started to erode
this barrier. In addition, domain decomposition methods (Chen
et al., 2007; Tapia and D’Souza, 2011) and the ability to parallelise
computations on large scales on commercially available graphics
processing units (Chen et al., 2007; Tapia and D’Souza, 2011;
Harvey et al., 2015) has made agent-based simulations achievable
universally.
Here, we have focussed on a specific type of agent-based
model. This is based on a discrete particle formulation, where
each cell is parameterized by a finite area and location. Broadly,
agent-based models can be divided into lattice-based and lattice-
free methods (Plank and Simpson, 2012). The discrete particle
approach is lattice-free, meaning that cells are free to move
anywhere in the domain. One limitation of this approach is
that the cells are restricted to be described as circles; that is,
their shape cannot be deformed. Immune cell deformation may
play an important role when considering how cells pass through
degraded parts of the basement membrane. In the current model
formulation, cells must “wait” until the gaps in the membrane are
sufficiently large before they can pass through.
An alternative to the discrete particle formulation is the
lattice-based cellular Potts model. This modeling framework has
been growing in popularity and has been applied to cell migration
in a number of contexts, including vasculogenesis (Merks et al.,
2006; Daub and Merks, 2013), morphogenesis (Chen et al., 2007;
Marée et al., 2007) and wound healing (Scianna, 2015). Although
the cellular Potts model is lattice-based, the cells within the
framework can occupy many lattice sites and thus their shape, as
well as their location, evolves over time. On a fine enough lattice,
such models can look remarkably similar to the system they are
approximating. However, with the increase in spatial resolution
of the lattice comes an associated computational cost. It should
be noted that there are several actively maintained packages for
agent-based modeling, such as CHASTE (Mirams et al., 2013)
and CompuCell3D (Swat et al., 2012).
One approach that combines the flexibility of lattice-free
approaches together whilst allowing for cells to change shape
is to treat points on the cell membrane as particles and resolve
forces acting upon them, under the assumption that the cell
remains bounded by its membrane (Elliott et al., 2012). However,
the mathematical machinery and computing power required
to embed such a description into our domain are prohibitive
for our purposes. A “halfway” house could, in which the cells
are treating as deformable ellipsoids, is another possible way of
relaxing our assumption that cells are perfectly circular (Palsson
and Othmer, 2000).
5.1. Future Directions
Themodeling framework described within this manuscript is not
intended to be a fully comprehensive endpoint for the study of
the spatio-temporal dynamics associated with insulitis. Instead,
it is intended to be the first step to building a general virtual
environment in which to simulate the invasion of islets during
T1D. We will now highlight some potential areas for model
development.
5.1.1. Geometry
We have treated perhaps the simplest possible geometry that is
reflective of the islet. The model is planar in nature, whereas real
islets and immune cells are three dimensional structures.We have
ignored the mechanical effects on the basement membrane: as
beta cells are removed from the islet, the morphology of the islet
itself may change (Brereton et al., 2014). There is currently no
structure imposed upon the extra-islet space. Accurate modeling,
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for example, in which the vasculature is taken into account may
constrain locations at which immune cells are allowed to enter
the domain. Through the use of imaging techniques, it should be
possible to build a more faithful representation of both the intra-
and extra-islet space and include these in the model.
5.1.2. Different Cell Types
The model could be developed to include more cell types, such
as the macrophages that clear apoptotic beta cells, or different
endocrine and exocrine cells which are not targeted by immune
cells, but may slow their movement. There may be other cell-cell
interactions that may be important during insulitis, for example
the role of CD4+ cells in the activation of CD8+ cells (Castiglioni
et al., 2005). Even restricting the model to the two immune cell
types described in this manuscript, we could consider different
clonal populations of the T cells (Khadra et al., 2011). One
hypothesized strategy to slow the progression of insulitis is to
promote the replication of a low avidity clone of T cells, that will
out compete the higher avidity clones for space and resources,
leaving only relatively passive T cells (Amrani et al., 2000; Khadra
et al., 2009; Bluestone et al., 2015). Such a mechanism could be
tested in our modeling framework.
5.1.3. Cell Proliferation
Currently, none of the cell types included in the model undergo
cell division. In general, post-natal beta cell replication in humans
is thought to occur at low rates, and we have disregarded
it here. Similarly, immune cell replication in and around the
islet is also assumed to be negligible. However, there is some
evidence to suggest both that beta cell proliferation is enhanced
during insulitis, at least during its early phases (Willcox et al.,
2010; Dirice et al., 2014) and that immune cell replication also
takes place within the islet itself (Graham et al., 2012) in the
NOD model, though these findings have not been corroborated
in human tissue. In particular, data collected from ex vivo
human samples suggested that very few lymphocytes in the
peri-islet space were positive for proliferative markers (Willcox
et al., 2010). In order for the hypothesis of promotion of low
avidity clones to be tested, the model would have to include
cell division, since the action of long-lived memory cells is an
integral part of that theory, however this may require coupling
of the agent-based model with one representing the lymphatic
system.
5.1.4. Multiple Islets
One of the striking features of insulitis is its heterogeneity,
even within an individual patient. Islets near to one another
can display different inflammatory profiles—insulitis in one islet
thus does not imply insulitis in nearby islets. By extending our
domain to include multiple islets, we can use the modeling
framework to investigate under what scenarios this can occur.
In particular, we can hope to identify what cellular interactions,
on a broad scale, must occur for such heterogeneity in disease
progression to be observed. One simple way to incorporate the
influence of other islets in the current framework would be to
include additional point sources of chemokine outside of the
working domain. This would have subtle effects on the dynamics
of cell movement, particularly when the number of beta cells
becomes low.
5.1.5. Membrane Degradation
In the current model prescription, the membrane integrity is
assumed to be compromised in a simple way by the action
of nearby immune cells. This process is solely dependent on
the proximity of the immune cells to the membrane. A more
sophisticated approach might be to model the cells secreting
proteases which diffuse freely and erode the membrane when
they meet it. Whilst this is perhaps better fitted to the true
processes that degrade the membrane, it is still not clear which
cells are responsible for mediating this process. One potential
route would thus be to consider the effects of having different
immune cells responsible for this process within the modeling
framework.
5.1.6. Waxing and Waning
One of the phenomena not accounted for in our description
is the honeymoon period (Akirav et al., 2008). This is a phase
lasting, in some cases, up to and beyond a year, typically
immediately following diagnosis, in which the requirement for
exogenous insulin is diminished. Though understanding of the
mechanisms giving rise to this transient asymptomatic period is
poor, one notable theoretical study demonstrated that this can
occur naturally (in rare cases) when taking into account the
role of endoplasmic reticulum stress and subsequent beta cell
apoptosis (Jaberi-Douraki et al., 2014c). This study highlighted
the possibility that elevations in the maximal unfolded protein
response due to metabolic therapies could benefit patients by
helping to meet metabolic demand, but despite this, they could
not ultimately maintain a sufficient population of healthy beta
cells to regulate blood glucose levels.
It is not clear whether the honeymoon period is reflective of
events occurring at the level of individual islets, whether it is only
present at the systemic level and whether it arises as a result of
some innate periodicity present in either the immune system or
in the beta cells. Modeling studies involving multiple islets may
help to address some of these questions.
5.1.7. Therapeutic Intervention
Once a realistic geometry, motivated by real data, has been
constructed, and the model sufficiently developed, an ultimate
goal would be to test therapeutic interventions that target the
pancreas specifically, such as the transplantation/implantation
of encapsulated islets or populations of beta cells (Rickels et al.,
2005; Robertson, 2010). We have discussed one hypothesis
involving the promotion of low avidity T cell clones (Amrani
et al., 2000; Khadra et al., 2009). One potential method for
doing this is through the intravenous injection of ex vivo-selected
and ex vivo-expanded autologous regulatory T cells, such as
CD4+ cells (Bluestone et al., 2015), another is to incite the same
expansion of regulatory T cells in vivo through the intravenous
injection of nanoparticles coated with pMHC (Sugarman et al.,
2013). Our modeling framework could easily be extended to
include the effect of infusion of either the cells themselves or the
nanoparticles to test the spatial aspects of these interventions.
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5.1.8. Cell-Cell Coupling
It is evident from the multiple sources of data that
communication between immune cells is an important aspect
of insulitis, though the exact processes by which these cells
exchange information is unknown. One potential avenue of
investigation is to assess specific cell interactions based on
known immunological mechanisms (Huppa and Davis, 2003;
Friedl et al., 2005). These can be incorporated into an agent-
based model to see what the overall effects of these specific types
of interaction are, with a view to identifying which signaling
pathways are most likely to result in the behavior observed in
patient data (McLennan et al., 2012).
5.1.9. Comparison with Animal Models
Animal models, and in particular, the NOD mouse model have
been extensively used to unravel potential causes and treatment
options for human T1D. That true parallels between the disease
in rodents and man may be fewer than is ideal, and the
fact that treatments that work in mice are not as efficacious
in humans (In’t Veld, 2014) has led to questions about the
suitability of animal models for human disease. From a modeling
perspective, this opens up interesting questions. In particular, is
it that the underlying mechanisms of insulitis truly are different
between different species, or are some processes universal, albeit
with potential different time courses and parameters? The former
suggests that in order to find a cure for human T1D, only focus on
the human condition is likely to yield fruitful results. However,
the latter option suggests that, if relations between mice and
men for those preserved pathways can be found, that the models
can still provide vital insights. An in silico modeling framework
seems like a natural place to address such a question as it allows
quantitative probing of such relationships.
5.1.10. Experimental Design
One of the critical factors hindering progress in understanding
T1D is the lack of human pancreatic samples from which to
extract data. Moreover, these provide data only at one specific
timepoint, so that very little is known about the time course of
insulitis in humans.
One role for mathematical modeling is to identify avenues to
explore to aid our understanding of disease mechanisms. The
present study has suggested that the balance between repair and
degradation of the peri-islet basement membrane surrounding
the islets is a critical factor which determines the overall rate
of beta cell destruction. Presently, little is known about the
composition of this membrane in humans, though recent studies
have identified its components in both healthy and infiltrated
islets in the NOD mouse (Korpos et al., 2013). We thus feel
that gaining an improved understanding of the structure of
the human peri-islet basement membrane will significantly our
improve understanding of insulitis.
Results from the agent-based model also suggest that the
chemoattractant produced by the beta cells, and the lymphocytes’
response to it is also important for governing disease progression.
As such, in vitro experiments to assess and quantify the rate of
immune cell migration to candidate chemokines would be useful
to explore how immune cells initially reach the islet.
Finally, little is understood about the interaction between
CD20+ and CD8+ cells during insulitis. The co-localization
of these immune cell types in pancreatic samples suggest an
interaction between the two (Huppa and Davis, 2003), and as
such, we speculate that this could give rise to the activation of
T cells. However, experiments have yet to confirm this for the
immune cells involved in human T1D. Moreover, the specific
dynamics of this process need to be better understood before the
true role of the CD20+ cells in human insulitis can be revealed.
Overall, we believe that the proposed spatio-temporal
framework has great potential as a tool to investigate insulitis in
humans, and by focussing attention on the pancreas, it maximizes
the use of the currently available human tissue data. We have
identified a number of potential avenues in which the framework
could be developed and a number of questions that could be
addressed in doing so and we hope to continue in this line of
research.
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Video S1 | Typical example of agent-based model simulation using
parameters in Table 1, with immune cell lifespans of 28 days and B = 5.
Video S2 | Typical example of agent-based model simulation using
parameters in Table 1, with immune cell lifespans of 28 days and B = 30.
Video S3 | Typical example of agent-based model simulation with no
peri-islet membrane repair, as indicated in Section 4.2 with immune cell
lifespans of 28 days, and B = 5.
Video S4 | Typical example of agent-based model simulation with no
peri-islet membrane repair, as indicated in Section 4.2 with immune cell
lifespans of 28 days, and B = 30.
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Video S5 | Typical example of agent-based model simulation with high
rates of peri-islet membrane degradation, as indicated in Section 4.3 with
immune cell lifespans of 28 days, and B = 5.
Video S6 | Typical example of agent-based model simulation with high
rates of peri-islet membrane degradation, as indicated in Section 4.3 with
immune cell lifespans of 28 days, and B = 30.
Video S7 | Typical example of agent-based model simulation using in the
high chemokine regime, as indicated in Section 4.5 with immune cell
lifespans of 28 days, and B = 5.
Video S8 | Typical example of agent-based model simulation using in the
high chemokine regime, as indicated in Section 4.5 with immune cell
lifespans of 28 days, and B = 30.
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